ESR1 and neoplasm: Co-treatment with 50 or 100 mg/kg GbE did not alter the anti-proliferative effect of TAM in ER-α-positive live tumor tissues, demonstrating that GbE does not compete with TAM for ER binding by acting as an ER agonist or antagonist.